{"altmetric_id":1555344,"counts":{"readers":{"mendeley":2,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["291286767653940"],"posts_count":1},"total":{"posts_count":5},"twitter":{"unique_users_count":4,"unique_users":["InOncology","Protein53com","ElizBlanchardMD","reTouchMD"],"posts_count":4}},"selected_quotes":["Supplement not effective for treatment of chemo induced neuropathy #supportiveonc"],"citation":{"altmetric_jid":"4f6fa4f73cf058f610002fd1","authors":["Michael Granovetter"],"doi":"10.1016\/s1470-2045(13)70284-5","first_seen_on":"2013-06-14T00:44:26+00:00","issns":["1470-2045"],"journal":"Lancet Oncology","last_mentioned_on":1372465983,"links":["http:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(13)70284-5\/fulltext?rss=yes"],"pdf_url":"http:\/\/download.thelancet.com\/pdfs\/journals\/lanonc\/PIIS1470204513702845.pdf","publisher":"Elsevier","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["neoplasms"],"title":"Acetyl-L-carnitine ineffective in treatment of CIPN","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/acetyllcarnitine-ineffective-treatment-cipn"},"altmetric_score":{"score":3.1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3.1},"context_for_score":{"all":{"total_number_of_other_articles":6241369,"mean":5.958650196241,"rank":1389987,"this_scored_higher_than_pct":77,"this_scored_higher_than":4836977,"rank_type":"exact","sample_size":6241369,"percentile":77},"similar_age_3m":{"total_number_of_other_articles":99596,"mean":7.4067221647673,"rank":27122,"this_scored_higher_than_pct":72,"this_scored_higher_than":72150,"rank_type":"exact","sample_size":99596,"percentile":72},"this_journal":{"total_number_of_other_articles":3010,"mean":14.735804586241,"rank":1412,"this_scored_higher_than_pct":52,"this_scored_higher_than":1585,"rank_type":"exact","sample_size":3010,"percentile":52},"similar_age_this_journal_3m":{"total_number_of_other_articles":80,"mean":1.9631392405063,"rank":12,"this_scored_higher_than_pct":85,"this_scored_higher_than":68,"rank_type":"exact","sample_size":80,"percentile":85}}},"demographics":{"poster_types":{"member_of_the_public":3,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":4}},"mendeley":{"by_status":{"Student  > Doctoral Student":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":1,"Biochemistry, Genetics and Molecular Biology":1}}},"geo":{"twitter":{"IN":1,"US":1}}},"posts":{"facebook":[{"title":"[News] Acetyl-L-carnitine ineffective in treatment of CIPN","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=428137137302235&id=291286767653940","license":"public","citation_ids":[1555344],"posted_on":"2013-06-29T00:33:03+00:00","summary":"Previous studies had indicated that Acetyl-L-carnitine (ALC), a natural agent that enhances neuronal protection, might be a useful treatment option for patients with chemotherapy-induced peripheral neuropathy (CIPN). But, results from a recent phase \u2026","author":{"name":"Journal Club for Basic Bio-Medical Sciences & Clinical Medicine","url":"https:\/\/www.facebook.com\/291286767653940","facebook_wall_name":"Journal Club for Basic Bio-Medical Sciences & Clinical Medicine","image":"https:\/\/graph.facebook.com\/291286767653940\/picture","id_on_source":"291286767653940"}}],"twitter":[{"url":"http:\/\/twitter.com\/InOncology\/statuses\/345340836441096192","license":"datasift","citation_ids":[1555344],"posted_on":"2013-06-14T00:44:06+00:00","author":{"name":"India Oncology 2.0","url":"https:\/\/www.facebook.com\/pages\/InOncology\/149384831739338","image":"https:\/\/pbs.twimg.com\/profile_images\/1075687841\/12_normal.png","description":"The Latest in Oncology","id_on_source":"InOncology","tweeter_id":"166079744","geo":{"lt":20,"ln":77,"country":"IN"},"followers":134},"tweet_id":"345340836441096192"},{"url":"http:\/\/twitter.com\/Protein53com\/statuses\/350763754151088131","license":"datasift","citation_ids":[1555344],"posted_on":"2013-06-28T23:52:50+00:00","author":{"name":"Protein53 Search LLC","url":"http:\/\/www.protein53.com","image":"https:\/\/pbs.twimg.com\/profile_images\/3272726542\/513a074e278c0ba6922a16a6125fd28d_normal.png","description":"Protein53 is a search portal that reaches across all cancer related News, Feeds,Gov. sites and cancer conference \ufb01ndings to deliver relevant search results","id_on_source":"Protein53com","tweeter_id":"1187235614","geo":{"lt":41.99038,"ln":-70.97504,"country":"US"},"followers":418},"tweet_id":"350763754151088131"},{"url":"https:\/\/twitter.com\/ElizBlanchardMD\/status\/348109225492357120","license":"public","citation_ids":[1555344],"posted_on":"2013-06-21T16:04:41+00:00","author":{"name":"ElizBlanchardMD","image":"https:\/\/pbs.twimg.com\/profile_images\/460263627086643200\/CYkK8EAR_normal.jpeg","description":"Chief, Hematology and Oncology at #southcoasthealth  Interests in lung cancer, supportive oncology #supponc","id_on_source":"ElizBlanchardMD","tweeter_id":"151835337","geo":{"lt":null,"ln":null},"followers":1214},"tweet_id":"348109225492357120"},{"url":"http:\/\/twitter.com\/reTouchMD\/statuses\/348111429179678720","license":"public","rt":["ElizBlanchardMD"],"citation_ids":[1555344],"posted_on":"2013-06-21T16:13:26+00:00","author":{"name":"reTouch Neuropathy","url":"http:\/\/t.co\/n1ho2Ssyou","image":"http:\/\/a0.twimg.com\/profile_images\/3651129767\/350490e8ed2418e946df704d338c7d38_normal.jpeg","description":"reTouch is the first medical device designed to restore sensation to those suffering with peripheral neuropathy. Please contact us for ordering information!","id_on_source":"reTouchMD","tweeter_id":"1423906260","followers":233},"tweet_id":"348111429179678720"}]}}